Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study

International Journal of Obesity volume 32, pages S11–S16 (2008)Cite this article

Abstract

Objectives:

We aimed (1) to construct a modified PROCAM risk algorithm, which incorporates BMI/waist circumference in a model for predicting coronary events; (2) to evaluate how accurate this and the previously established PROCAM risk algorithm predict coronary risk in individuals with metabolic syndrome.

Design:

Prospective Cardiovascular Münster (PROCAM) Study, a prospective study of men and women at work in the northwest of Germany.

Subjects:

A total of 7134 men aged 35–65 years at study entry.

Measurements:

On the basis of 404 major coronary events (defined as nonfatal MI and coronary deaths), which occurred within 10 years of follow-up, a modified PROCAM risk algorithm was constructed by incorporating BMI/waist circumference as fixed variable in a Cox proportional hazards model for predicting coronary events. The metabolic syndrome was defined according to the latest recommendations proposed by the NCEP-ATP III Panel.

Results:

Men who were classified as having the metabolic syndrome (n=2325, prevalence: 32.6%) were 2.59-fold more likely to experience a major coronary event within 10 years of follow-up than men not having the metabolic syndrome. In men with metabolic syndrome, the observed major coronary event rate of 9.6% corresponded well with their estimated global risk according to the modified BMI-based PROCAM risk algorithm (10.2%). Comparative calculations performed with the previously published fully adjusted PROCAM algorithm yielded very similar results.

Conclusion:

Both PROCAM algorithms provide very accurate means to ascertain coronary risk in male patients with metabolic syndrome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M . Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006; 27: 1610–1619.

    Article  Google Scholar 

  2. Flegal KM, Carroll MD, Ogden CL, Johnson CL . Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–1727.

    Article  Google Scholar 

  3. Ford ES . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769–1778.

    Article  Google Scholar 

  4. Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.

    Article  CAS  Google Scholar 

  5. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138–1145.

    Article  CAS  Google Scholar 

  6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  Google Scholar 

  7. Alberti KG, Zimmet P, Shaw J . The metabolic syndrome—a new worldwide definition. Lancet 2005; 366: 1059–1062.

    Article  Google Scholar 

  8. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007; 99: 541–548.

    Article  Google Scholar 

  9. Despres JP, Lemieux I . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.

    Article  CAS  Google Scholar 

  10. Assmann G, Cullen P, Schulte H . The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J 1998; 19: A2–A11.

    PubMed  Google Scholar 

  11. Cullen P, Schulte H, Assmann G . The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997; 96: 2128–2136.

    Article  CAS  Google Scholar 

  12. Assmann G, Cullen P, Schulte H . Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310–315.

    Article  Google Scholar 

  13. Assmann G, Schulte H . Results and conclusions of the Prospective Cardiovascular Münster (PROCAM) Study. In: Assmann G (ed). Lipid Metabolism Disorders and Coronary Heart Disease. MMV Medizin Verlag: München, 1993, pp 19–68.

    Google Scholar 

  14. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes 2001; 25: 1782–1788.

    Article  CAS  Google Scholar 

  15. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087–2094.

    Article  CAS  Google Scholar 

  16. Nakamura T, Tokunga K, Shimomura I, Nishida M, Yoshida S, Kotani K et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239–246.

    Article  CAS  Google Scholar 

  17. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643–1649.

    Article  CAS  Google Scholar 

  18. Nesto RW . The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med 2003; 4: S11–S18.

    PubMed  Google Scholar 

  19. Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119: 812–819.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leibniz-Institute of Arteriosclerosis Research, University of Münster, Münster, Germany

    G Assmann, H Schulte & U Seedorf

  2. Institute of Clinical Chemistry and Laboratory Medicine, University of Münster, Münster, Germany

    G Assmann

Authors
  1. G Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U Seedorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Assmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assmann, G., Schulte, H. & Seedorf, U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes 32 (Suppl 2), S11–S16 (2008). https://doi.org/10.1038/ijo.2008.29

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.29

Keywords

This article is cited by

Search

Advanced search

Quick links